Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

JAK inhibitors and autoimmune rheumatic diseases
Maurizio Benucci, Pamela Bernardini, Carmela Coccia, et al.
Autoimmunity Reviews (2023) Vol. 22, Iss. 4, pp. 103276-103276
Open Access | Times Cited: 64

Showing 1-25 of 64 citing articles:

T follicular helper cells and T follicular regulatory cells in autoimmune diseases
Jingjing Qi, Chang Liu, Ziran Bai, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 29
Risk of herpes zoster associated with JAK inhibitors in immune-mediated inflammatory diseases: a systematic review and network meta-analysis
Qingling Xu, Liyuan He, Yufeng Yin
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 28
Idiopathic inflammatory myopathies: current insights and future frontiers
Caoilfhionn M Connolly, Latika Gupta, Manabu Fujimoto, et al.
The Lancet Rheumatology (2024) Vol. 6, Iss. 2, pp. e115-e127
Open Access | Times Cited: 11
Advances in local drug delivery technologies for improved rheumatoid arthritis therapy
Xiaoran An, Jiapei Yang, Xiaolin Cui, et al.
Advanced Drug Delivery Reviews (2024) Vol. 209, pp. 115325-115325
Closed Access | Times Cited: 8
Skatole Alleviates Osteoarthritis by Reprogramming Macrophage Polarization and Protecting Chondrocytes
Weiyun Wang, Yaru Chu, Yunkun Lu, et al.
Research (2025) Vol. 8
Open Access | Times Cited: 1
Insight into Janus kinases specificity: From molecular architecture to cancer therapeutics
Tian‐Hua Wei, Meng‐Yi Lu, Sihui Yao, et al.
MedComm – Oncology (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 7
Broader Perspective on Atherosclerosis—Selected Risk Factors, Biomarkers, and Therapeutic Approach
Piotr Fularski, Witold Czarnik, Bartłomiej Dąbek, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5212-5212
Open Access | Times Cited: 5
The interferon in idiopathic inflammatory myopathies: Different signatures and new therapeutic perspectives. A literature review
Michela Gasparotto, Chiara Franco, Elisabetta Zanatta, et al.
Autoimmunity Reviews (2023) Vol. 22, Iss. 6, pp. 103334-103334
Open Access | Times Cited: 14
Exploring the mechanism of Celastrol in the treatment of rheumatoid arthritis based on systems pharmacology and multi-omics
Liuting Zeng, Ganpeng Yu, Kailin Yang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Gene regulatory network inference from CRISPR perturbations in primary CD4+ T cells elucidates the genomic basis of immune disease
Joshua S. Weinstock, Maya M. Arce, Jacob W. Freimer, et al.
Cell Genomics (2024) Vol. 4, Iss. 11, pp. 100671-100671
Open Access | Times Cited: 4
Tooth Extraction as a Potential Risk Factor for Refractory Osteitis and Controversy of Using JAK Inhibitor to Alleviate Inflammation in SAPHO Syndrome
Alison Prosper, Rémi Esclassan, Thibault Canceill
International Journal of Rheumatic Diseases (2025) Vol. 28, Iss. 1
Closed Access
Identifying potential mechanism and targets for treatment of tertiary lymphoid structure in lupus nephritis based on bioinformatics analysis
Mengxiao Zou, Duo Qian, Ran Luo, et al.
International Immunopharmacology (2025) Vol. 148, pp. 114084-114084
Open Access
Callistephus A from Callistephus chinensis Nees alleviates concanavalin A-induced immunological liver injury in mice by inhibiting the activation of JAK/STAT1 and MAPK signaling pathways
Haonan Fu, Xiaojun Wang, Mingyuan Yuan, et al.
International Immunopharmacology (2025) Vol. 148, pp. 114153-114153
Closed Access
Biomaterials for Modulating the Immune Microenvironment in Rheumatoid Arthritis
Qiaoxuan Wang, Juan Ji, Ding Huang, et al.
BME Frontiers (2025) Vol. 6
Open Access
Efficacy of Janus kinase inhibitors in immune-mediated inflammatory diseases—a systematic literature review informing the 2024 update of an international expert consensus statement
Victoria Konzett, Josef S Smolen, Peter Nash, et al.
Annals of the Rheumatic Diseases (2025)
Open Access
Efficacy and safety of mesenchymal stromal cell transplantation in the treatment of autoimmune and rheumatic immune diseases: a systematic review and meta-analysis of randomized controlled trials
Liuting Zeng, Chang Liu, Yang Wu, et al.
Stem Cell Research & Therapy (2025) Vol. 16, Iss. 1
Open Access
Novel janus kinase 3 inhibitor ritlecitinib suppresses T and B cell responses to prevent acute cardiac allograft rejection in mice
Rumin Liu, X Y Shi, Wenli Zeng, et al.
Clinical Immunology (2025) Vol. 273, pp. 110445-110445
Closed Access
Assessment of cardiovascular, thromboembolic and cancer risk in patients eligible for treatment with Janus Kinase inhibitors: The JAK-ERA multidisciplinary consensus
Lorenzo Dagna, Alessia Alunno, Nicola Farina, et al.
European Journal of Internal Medicine (2025)
Closed Access
Risk of serious infection with JAK inhibitors in immune-mediated inflammatory skin diseases: a meta-analysis of randomized clinical trials
Xinhong Su, Yanghang Ou, Shi‐Fan Ruan, et al.
Journal of Dermatological Treatment (2025) Vol. 36, Iss. 1
Open Access
Discovery of a new anti-γc antibody in clinical development for the treatment of autoimmune diseases
Chin Wai Hui, Wai Chung Wu, Tak Keung Tong, et al.
The Journal of Immunology (2025)
Closed Access
Recent developments for new investigational JAK inhibitors in psoriatic arthritis
Francesco Caso, Luisa Costa, Paola Triggianese, et al.
Expert Opinion on Investigational Drugs (2023) Vol. 32, Iss. 5, pp. 361-371
Closed Access | Times Cited: 11
Kunxian capsule alleviates renal damage by inhibiting the JAK1/STAT1 pathway in lupus nephritis
Chen Cheng, Rongrong Zhu, Mingjian Liu, et al.
Journal of Ethnopharmacology (2023) Vol. 310, pp. 116349-116349
Closed Access | Times Cited: 9
Periplogenin inhibits pathologic synovial proliferation and infiltration in rheumatoid arthritis by regulating the JAK2/3-STAT3 pathway
Xiaoqin Zhong, Wei Feng, Lianjie Liu, et al.
International Immunopharmacology (2024) Vol. 128, pp. 111487-111487
Closed Access | Times Cited: 3
ABBV-744 alleviates LPS-induced neuroinflammation via regulation of BATF2-IRF4-STAT1/3/5 axis
Lele Wang, Huan Wang, Sijin Lin, et al.
Acta Pharmacologica Sinica (2024)
Closed Access | Times Cited: 3
JAK inhibitors and black box warnings: what is the future for JAK inhibitors?
Yekaterina Tokareva, Pankti Reid, Victor Yang, et al.
Expert Review of Clinical Immunology (2023) Vol. 19, Iss. 11, pp. 1385-1397
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top